John P Finnigan

5PUBLICATIONS
46CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsPreventative health careCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2026
Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.

Andrew S Ishizuka, Christopher M Garliss, Robert N Goddu

|Mar 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.

Mansi Saxena, Thomas U Marron, Julia Kodysh

|Jun 06, 2020
Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity.

Barbara Maier, Andrew M Leader, Steven T Chen

|Apr 10, 2020
A conserved dendritic-cell regulatory program limits antitumour immunity.

Barbara Maier, Andrew M Leader, Steven T Chen

|Jul 04, 2019
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms.

Cansu Cimen Bozkus, Vladimir Roudko, John P Finnigan

Pageof 1

Frequent Collaborators

2 joint publications

Christie Chang

2 joint publications

Margaret E Kirkling

2 joint publications

Nina Bhardwaj

1 joint publications

Mansi Saxena